UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A critical appraisal of one‐stage and chromogenic assays of factor VIII activity

Journal of thrombosis and haemostasis, 2016-02, Vol.14 (2), p.248-261

2016

Volltextzugriff (PDF)

Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies

Journal of thrombosis and haemostasis, 2017-02, Vol.15 (2), p.312-322

2017

Volltextzugriff (PDF)

An optimized fluorogenic ADAMTS13 assay with increased sensitivity for the investigation of patients with thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2013-08, Vol.11 (8), p.1511-1518

2013

Volltextzugriff (PDF)

Urgent reversal of warfarin with prothrombin complex concentrate

Journal of thrombosis and haemostasis, 2006-05, Vol.4 (5), p.967-970

2006

Volltextzugriff (PDF)

International comparative field study evaluating the assay performance of AFSTYLA in plasma samples at clinical hemostasis laboratories

Journal of thrombosis and haemostasis, 2018-03, Vol.16 (3), p.555-564

2018

Volltextzugriff (PDF)

Performance of a recombinant fusion protein linking coagulation factor IX with recombinant albumin in one‐stage clotting assays

Journal of thrombosis and haemostasis, 2019-01, Vol.17 (1), p.138-148

2019

Volltextzugriff (PDF)

A computer‐based model to assess costs associated with the use of factor VIII and factor IX one‐stage and chromogenic activity assays

Journal of thrombosis and haemostasis, 2016-04, Vol.14 (4), p.757-764

2016

Volltextzugriff (PDF)

Critical von Willebrand factor A1 domain residues influence type VI collagen binding

Journal of thrombosis and haemostasis, 2012-07, Vol.10 (7), p.1417-1424

2012

Volltextzugriff (PDF)

Response: The coagulation laboratory monitoring of AFSTYLA single‐chain FVIII concentrate

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-05, Vol.24 (3), p.e129-e131

2018

Volltextzugriff (PDF)

Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD

Journal of thrombosis and haemostasis, 2010-06, Vol.8 (6), p.1431-1433

2010

Volltextzugriff (PDF)

Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease

Journal of thrombosis and haemostasis, 2012-07, Vol.10 (7), p.1425-1432

2012

Volltextzugriff (PDF)

Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR

Thrombosis and haemostasis, 1999-05, Vol.81 (5), p.733-738

1999

Volltextzugriff (PDF)

Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function

Journal of thrombosis and haemostasis, 2009-11, Vol.7 (11), p.1832-1839

2009

Volltextzugriff (PDF)

Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-11, Vol.21 (6), p.837-845

2015

Volltextzugriff (PDF)

Diagnostic challenges in patients with bleeding phenotype and von Willebrand exon 28 polymorphism p.D1472H

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-05, Vol.20 (3), p.e211-e214

2014

Volltextzugriff (PDF)

Genotyping of Factor V G1691A (Leiden) without the Use of PCR by Invasive Cleavage of Oligonucleotide Probes

Clinical chemistry (Baltimore, Md.), 2000-08, Vol.46 (8), p.1051-1056

2000

Volltextzugriff (PDF)

A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy

Transfusion (Philadelphia, Pa.), 1994-01, Vol.34 (1), p.66-71

1994

Volltextzugriff (PDF)

Thrombolytic Therapy With Tissue Plasminogen Activator or Streptokinase Induces Transient Thrombin Activity

Blood, 1988-08, Vol.72 (2), p.616-620

1988

Volltextzugriff (PDF)

Laboratory diagnosis of von Willebrand disease: results from a prospective and blind study in 32 laboratories worldwide using lyophilized plasmas

Journal of thrombosis and haemostasis, 2011-01, Vol.9 (1), p.220-222

2011

Volltextzugriff (PDF)

Allelic distribution of the glycoprotein Ia (α2‐integrin) C807T/G873A dimorphisms among Caucasian venous thrombosis patients and six racial groups

British journal of haematology, 1999-12, Vol.107 (3), p.563-565

1999

Volltextzugriff (PDF)

Multisite study for genotyping of the factor II (Prothrombin) G20210A mutation by the invader assay

Clinical chemistry (Baltimore, Md.), 2001-11, Vol.47 (11), p.2048-2050

2001

Volltextzugriff (PDF)

Measurement of von Willebrand factor cleaving protease (ADAMTS‐13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas

Journal of thrombosis and haemostasis, 2004-09, Vol.2 (9), p.1601-1609

2004

Volltextzugriff (PDF)

Platelet‐dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2015-07, Vol.13 (7), p.1345-1350

2015

Volltextzugriff (PDF)

On improving the cost-effectiveness of autologous blood transfusion practices

Transfusion (Philadelphia, Pa.), 1994-03, Vol.34 (3), p.259-264

1994

Volltextzugriff (PDF)

Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease

The Journal of biological chemistry, 1991-10, Vol.266 (29), p.19146-19149

1991

Volltextzugriff (PDF)

1 – 25 von 3.748

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.332)
Mit Volltextzugriff
(2.971)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.458)
Life Sciences & Biomedicine
(1.961)
Humans
(1.742)
Female
(1.143)
Male
(1.039)
Biological And Medical Sciences
(1.027)
Medical Sciences
(877)
Adult
(688)
Middle Aged
(609)
Aged
(469)
Animals
(392)
Physical Sciences
(362)
Adolescent
(310)
Neurosciences & Neurology
(244)
Child
(236)
Physics
(234)
Oncology
(219)
Risk Factors
(219)
Fundamental And Applied Biological Sciences. Psychology
(193)
Cardiovascular System & Cardiology
(190)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(2.028)
EZB Electronic Journals Library
(1.675)
Journals@Ovid Ovid Full Text
(1.550)
Ingenta
(1.420)
Publisher or Other Site
(1.342)
Elsevier ScienceDirect Journals Complete
(807)
IngentaConnect Journals
(606)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(451)
Wiley Online Library
(398)
Wiley Online Library
(289)
Oxford journals
(216)
SpringerLink
(208)
Oxford Journals 2020 Medicine
(193)
JSTOR
(137)
Nature - Journals : Nature ; Nature Climate Change
(130)
American Physical Society Journals
(128)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(122)
PROLA - Physical Review Online Archive
(104)
Taylor & Francis
(95)
Psychology and Behavioral Sciences Collection
(91)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(21)

Menü

Weitere Dienste

Einstellungen

A critical appraisal of one‐stage and chromogenic assays of factor VIII activity

Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies

An optimized fluorogenic ADAMTS13 assay with increased sensitivity for the investigation of patients with thrombotic thrombocytopenic purpura

Urgent reversal of warfarin with prothrombin complex concentrate

International comparative field study evaluating the assay performance of AFSTYLA in plasma samples at clinical hemostasis laboratories

Performance of a recombinant fusion protein linking coagulation factor IX with recombinant albumin in one‐stage clotting assays

A computer‐based model to assess costs associated with the use of factor VIII and factor IX one‐stage and chromogenic activity assays

Critical von Willebrand factor A1 domain residues influence type VI collagen binding

Response: The coagulation laboratory monitoring of AFSTYLA single‐chain FVIII concentrate

Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD

Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease

Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR

Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function

Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method

Diagnostic challenges in patients with bleeding phenotype and von Willebrand exon 28 polymorphism p.D1472H

Genotyping of Factor V G1691A (Leiden) without the Use of PCR by Invasive Cleavage of Oligonucleotide Probes

A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy

Thrombolytic Therapy With Tissue Plasminogen Activator or Streptokinase Induces Transient Thrombin Activity

Laboratory diagnosis of von Willebrand disease: results from a prospective and blind study in 32 laboratories worldwide using lyophilized plasmas

Allelic distribution of the glycoprotein Ia (α2‐integrin) C807T/G873A dimorphisms among Caucasian venous thrombosis patients and six racial groups

Multisite study for genotyping of the factor II (Prothrombin) G20210A mutation by the invader assay

Measurement of von Willebrand factor cleaving protease (ADAMTS‐13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas

Platelet‐dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH

On improving the cost-effectiveness of autologous blood transfusion practices

Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease

Suchergebnisse filtern